Andrew D. Sklawer

Chief Operating Officer, Fresh Tracks Therapeutics, Inc.

Companies

Fresh Tracks Therapeutics, Inc.Chief executive officer Oct 4, 2023 to Oct 4, 2023¹
Fresh Tracks Therapeutics, Inc.President Jan 26, 2023 to Oct 4, 2023²
Fresh Tracks Therapeutics, Inc.Chief operating officer Sep 9, 2019 to May 9, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fresh Tracks Therapeutics, Inc.39,269 shares⁴Oct 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 2, 2023Shares withheld for tax 20,833 shares at $0.98 of Fresh Tracks Therapeutics, Inc.⁴
Oct 2, 2023Exercised options 55,000 shares of Fresh Tracks Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFresh Tracks Therapeutics, Inc., Chief executive officer
2
SEC EDGARFresh Tracks Therapeutics, Inc., President
3
SEC EDGARFresh Tracks Therapeutics, Inc., Chief operating officer
4
SEC EDGARFresh Tracks Therapeutics, Inc. shares after the filing of Oct 2, 2023